Loading data
CROXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.04 bn USD | 4.1 bn USD | 3.96 bn USD | 3.55 bn USD | 2.31 bn USD |
| Cost of revenue | 1.68 bn USD | 1.69 bn USD | 1.75 bn USD | 1.69 bn USD | 893.2 m USD |
| Gross profit | 2.36 bn USD | 2.41 bn USD | 2.21 bn USD | 1.86 bn USD | 1.42 bn USD |
| Research and development expense | 29.6 m USD | 25.6 m USD | 21.4 m USD | 18.7 m USD | 13.7 m USD |
| Selling, general and administrative expense | 1.47 bn USD | 1.36 bn USD | 1.16 bn USD | 1.01 bn USD | 737.16 m USD |
| Operating profit | 149.52 m USD | 1.02 bn USD | 1.04 bn USD | 850.76 m USD | 683.06 m USD |
| Interest expense | — | — | 161.35 m USD | 136.16 m USD | 21.65 m USD |
| Profit before tax | 72.98 m USD | 910.59 m USD | 876.27 m USD | 718.51 m USD | 663.85 m USD |
| Income tax expense | 154.18 m USD | -39.49 m USD | 83.71 m USD | 178.35 m USD | -61.85 m USD |
| Net income (reported basis) | -81.2 m USD | 950.1 m USD | 792.6 m USD | 540.2 m USD | 725.7 m USD |
| Net income attributable to common shareholders | -81.2 m USD | 950.07 m USD | 792.57 m USD | 540.16 m USD | 725.69 m USD |
| Basic earnings per share | -1.5 USD/share | 16 USD/share | 12.91 USD/share | 8.82 USD/share | 11.62 USD/share |
| Diluted earnings per share | -1.5 USD/share | 15.88 USD/share | 12.79 USD/share | 8.71 USD/share | 11.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.